Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
481
mi
from 43215
New York, NY
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
698
mi
from 43215
Fort Smith, AR
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
698
mi
from 43215
Fort Smith, AR
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
2091
mi
from 43215
Santa Clara, CA
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
2091
mi
from 43215
Santa Clara, CA
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
328
mi
from 43215
Washington,
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
288
mi
from 43215
Park Ridge, IL
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
288
mi
from 43215
Park Ridge, IL
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
627
mi
from 43215
St. Joseph, MO
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
627
mi
from 43215
St. Joseph, MO
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia -Targeted Affective Remediation Approach (TARA)
Status: Enrolling
Updated:  5/13/2013
San Francisco Veterans Affairs Medical Center
2111
mi
from 43215
San Francisco, CA
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia -Targeted Affective Remediation Approach (TARA)
Status: Enrolling
Updated: 5/13/2013
San Francisco Veterans Affairs Medical Center
2111
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia -Targeted Affective Remediation Approach (TARA)
Status: Enrolling
Updated:  5/13/2013
Langley Porter Psychiatric Institute, UCSF
2107
mi
from 43215
San Francisco, CA
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia -Targeted Affective Remediation Approach (TARA)
Status: Enrolling
Updated: 5/13/2013
Langley Porter Psychiatric Institute, UCSF
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
732
mi
from 43215
Pascagoula, MS
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
732
mi
from 43215
Pascagoula, MS
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
477
mi
from 43215
Teaneck, NJ
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
477
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
482
mi
from 43215
Bronx, NY
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
302
mi
from 43215
Asheville, NC
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
302
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
400
mi
from 43215
Allentown, PA
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
400
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated:  5/22/2013
Clinical Research Facility
991
mi
from 43215
Houston, TX
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
Status: Enrolling
Updated: 5/22/2013
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1654
mi
from 43215
Chandler, AZ
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1654
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1960
mi
from 43215
Anaheim, CA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1960
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1949
mi
from 43215
National City, CA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1949
mi
from 43215
National City, CA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1949
mi
from 43215
Oceanside, CA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1949
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1950
mi
from 43215
San Diego, CA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
2020
mi
from 43215
Santa Ana, CA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
2020
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
1163
mi
from 43215
Highlands Ranch, CO
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
1163
mi
from 43215
Highlands Ranch, CO
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
510
mi
from 43215
Norwalk, CT
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
510
mi
from 43215
Norwalk, CT
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
786
mi
from 43215
Altamonte Springs, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
786
mi
from 43215
Altamonte Springs, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
861
mi
from 43215
Bradenton, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
861
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
978
mi
from 43215
Hollywood, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
788
mi
from 43215
Maitland, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
983
mi
from 43215
Miami, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
983
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
986
mi
from 43215
North Miami, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
986
mi
from 43215
North Miami, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
767
mi
from 43215
Orange City, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
767
mi
from 43215
Orange City, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
830
mi
from 43215
Tampa, FL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
432
mi
from 43215
Atlanta, GA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
300
mi
from 43215
Hoffman Estates, IL
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
300
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials